Sichuan Huiyu Pharmaceutical Co., Ltd.
SSE:688553.SS
16.09 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 2,328.244 | 1,782.479 | 1,205.848 | 1,305.879 | 371.522 | 259.142 | 45.716 | 4.62 |
| Short Term Investments
| 688.592 | 789.052 | 1,375.905 | 1,662.156 | 228 | 178 | 0 | 0 |
| Cash and Short Term Investments
| 3,016.837 | 2,571.531 | 2,581.754 | 2,968.035 | 599.522 | 437.142 | 45.716 | 4.62 |
| Net Receivables
| 58.077 | 55.946 | 42.833 | 11.869 | 13.176 | 31.895 | 4.107 | 1.302 |
| Inventory
| 159.919 | 153.115 | 165.982 | 178.867 | 94.632 | 50.587 | 24.481 | 12.406 |
| Other Current Assets
| 109.516 | 89.563 | 82.638 | 64.389 | 53.435 | 44.547 | 27.809 | 22.885 |
| Total Current Assets
| 3,344.348 | 2,870.156 | 2,873.206 | 3,233.455 | 760.765 | 554.013 | 100.236 | 41.213 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 1,516.479 | 1,471.426 | 1,123.294 | 672.478 | 329.683 | 259.169 | 165.817 | 173.217 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 86.27 | 78.052 | 63.514 | 64.008 | 36.23 | 15.564 | 15.939 | 21.514 |
| Goodwill and Intangible Assets
| 86.27 | 78.052 | 63.514 | 64.008 | 36.23 | 15.564 | 15.939 | 21.514 |
| Long Term Investments
| -522.854 | 210.207 | -1,276.594 | -1,607.852 | 0 | 0 | -0 | 0 |
| Tax Assets
| 24.469 | 53.807 | 29.629 | 10.552 | 5.842 | 26.072 | 49.326 | 0 |
| Other Non-Current Assets
| 716.914 | 1.997 | 1,463.46 | 1,756.864 | 80.223 | 5.165 | 7.996 | 0.67 |
| Total Non-Current Assets
| 1,821.279 | 1,815.489 | 1,403.303 | 896.05 | 451.977 | 305.969 | 239.079 | 195.4 |
| Total Assets
| 5,165.627 | 4,685.645 | 4,276.51 | 4,129.505 | 1,212.742 | 859.982 | 339.315 | 236.613 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 197.033 | 133.894 | 95.522 | 59.246 | 29.506 | 17.004 | 13.397 | 19.523 |
| Short Term Debt
| 580.281 | 426.732 | 45.039 | 13.664 | 4.052 | 40.063 | 80 | 104.895 |
| Tax Payables
| 6.42 | 11.977 | 2.732 | 15.821 | 34.365 | 5.736 | 3.659 | 2.829 |
| Deferred Revenue
| 0 | 0 | 36.869 | 415.354 | 22.456 | 252.344 | 3.659 | 101.618 |
| Other Current Liabilities
| 353.015 | 306.722 | 383.101 | 368.529 | 333.25 | 66.089 | 201.835 | 233.86 |
| Total Current Liabilities
| 1,136.749 | 879.325 | 526.394 | 492.909 | 397.12 | 381.236 | 302.551 | 361.107 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 0 | 2.048 | 4.62 | 3.276 | 0 | 0 | 124.89 | 0 |
| Deferred Revenue Non-Current
| 48.98 | 0 | 22.154 | 24.206 | 14.119 | 12.417 | 12.578 | 10.83 |
| Deferred Tax Liabilities Non-Current
| 6.518 | 5.544 | 5.268 | 0.6 | -6.93 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -0 | 24.305 | 0 | 50.018 | 50.018 | 70.099 | 50 | 50 |
| Total Non-Current Liabilities
| 55.498 | 31.897 | 32.042 | 78.1 | 64.137 | 70.099 | 187.468 | 60.83 |
| Total Liabilities
| 1,192.246 | 911.222 | 558.435 | 571.008 | 461.258 | 451.335 | 490.019 | 421.937 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 423.6 | 423.6 | 423.6 | 423.6 | 360 | 134.526 | 118.048 | 110 |
| Retained Earnings
| 953.607 | 756.916 | 729.897 | 596.559 | 192.462 | -132.934 | -309.879 | -287.874 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 92.285 | 66.045 | 56.424 | 407.09 | 41.126 | 0 |
| Other Total Stockholders Equity
| 2,601.838 | 2,590.078 | 2,574.206 | 2,547.743 | 208.159 | 416.341 | 49.9 | -7.45 |
| Total Shareholders Equity
| 3,979.044 | 3,770.594 | 3,718.074 | 3,558.497 | 751.485 | 408.682 | -150.704 | -185.324 |
| Total Equity
| 3,973.38 | 3,774.423 | 3,718.074 | 3,558.497 | 751.485 | 408.647 | -150.704 | -185.324 |
| Total Liabilities & Shareholders Equity
| 5,165.627 | 4,685.645 | 4,276.51 | 4,129.505 | 1,212.742 | 859.982 | 339.315 | 236.613 |